Groupama Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Groupama Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.24M	Sell	20,410 -7,884	-28%	-$460K	0.02%	189
2025 Q4	$1.53M	Sell	28,294 -2,940	-9%	-$141K	0.02%	191
2025 Q3	$1.41M	Buy	31,234 +5,926	+23%	+$277K	0.02%	209
2025 Q2	$1.17M	Sell	25,308 -14,373	-36%	-$706K	0.02%	256
2025 Q1	$2.38M	Sell	39,681 -7,690	-16%	-$448K	0.05%	166
2024 Q4	$2.66M	Sell	47,371 -16,208	-25%	-$906K	0.05%	160
2024 Q3	$2.64M	Sell	63,579 -52,430	-45%	-$2.46M	0.07%	151
2024 Q2	$3.9M	Buy	116,009 +59,814	+106%	+$2.68M	0.05%	145
2024 Q1	$5.86M	Sell	56,195 -48,102	-46%	-$2.45M	0.11%	129
2023 Q4	$5.35M	Buy	+104,297	New	+$5.47M	0.14%	107

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Groupama Asset Management's BMY Position: Q1 2026 in Review

Groupama Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 28% in Q1 2026, selling an estimated $460K and leaving 20,410 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #189.

Groupama Asset Management first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.86M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Groupama Asset Management held 20,410 shares of Bristol-Myers Squibb worth $1.24M as of Q1 2026.
Groupama Asset Management sold 7,884 Bristol-Myers Squibb shares in Q1 2026, an estimated $460K.
Bristol-Myers Squibb made up 0.02% of Groupama Asset Management's portfolio in Q1 2026, its #189 holding.
Groupama Asset Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
Groupama Asset Management's Bristol-Myers Squibb position peaked at $5.86M in Q1 2024.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.